InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,588.97
(
-0.80%
)
US TECH 100
19,738.40
(
-1.89%
)
Dow Jones
39,764.56
(
0.11%
)
Brent Oil
84.96
(
-0.11%
)
Bitcoin
57,469.76
(
-0.48%
)
Post# of 643
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Alyssa

Send PM Follow Ignore
Followers 120
Posts 9122
Boards Moderated 0
Alias Born 07/17/2005

Alyssa

Re: None

Saturday, 08/28/2010 9:46:20 AM

Saturday, August 28, 2010 9:46:20 AM

Post# of 643
While Benda has its problems, it is hard to believe the share price continues to languish at these prices, especially because they are the owners of Gendicine, the first-ever approved and apparently effective gene therapy for cancer, among so many other positives.

Hmmm. Another no-brainer? I vote yes!




Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up